Northwestern University

iBIO Institute announces iCON Awards honorees

Tuesday, August 22, 2017

The iBIO Institute announced the four honorees of the eleventh annual iCON Awards—a prestigious honor for life sciences educators, researchers and civic visionaries. The iCON Awards celebrate the accomplishments of outstanding innovators and leaders whose work provides the basis for biotechnology developments worldwide.

[Read More]

MDA awards more than $7M in new research grants

Friday, March 10, 2017

The Muscular Dystrophy Association has announced the award of 29 new R&D grants totaling more than $7 million and targeted to impact the state of the science and accelerate the development of treatments for muscular dystrophy, ALS and related life-threatening diseases. The investment reflects MDA’s continued efforts to refocus resources in order to double research spending on drug development and clinical trials by 2020.

[Read More]

Enrollment strategies in the PMI Cohort Study will bolster diversity in clinical research industry-wide

Monday, July 25, 2016

The Precision Medicine Initiative (PMI) Cohort Program is an ambitious observational study backed by the National Institutes of Health (NIH) that seeks to enroll at least one million Americans by 2020. Because of its massive scale, the Cohort Program is often compared to the 1948 Framingham Heart Study. Yet a crucial differentiator is that the Cohort Program aims to recruit participants with diverse backgrounds and ethnicities to better understand the root cause of disease for all Americans.

[Read More]

NIH awards $55M to build million-person precision medicine study

Thursday, July 7, 2016

The NIH has announced $55 million in awards in fiscal year 2016 to build the foundational partnerships and infrastructure needed to launch the Cohort Program of President Obama’s Precision Medicine Initiative (PMI). The PMI Cohort Program is a landmark longitudinal research effort that aims to engage 1 million or more U.S. participants to improve our ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.

[Read More]

NIH seeks ways to combine genomic information and EHRs

Wednesday, September 9, 2015

A dozen awards from the NIH will support research that incorporates DNA sequence information into electronic medical records. The goal of research conducted by the Electronic Medical Records and Genomics (eMERGE) network is to better understand the genomic basis of disease and to tailor medical care to individual patients based on their genomic differences.

[Read More]

CardioCell adds Stony Brook University to sites conducting phase IIa trial

Thursday, March 12, 2015

CardioCell, a Stemedica Cell Technologies subsidiary that designs allogeneic stem-cell therapies for cardiovascular indications, has expanded patient recruitment to Stony Brook University’s Heart Institute for its phase IIa clinical trial for chronic heart failure (HF). Recruitment for 20 qualified patients currently is underway at only Emory University in Atlanta, Northwestern University in Chicago, Stony Brook University on Long Island and the University of Pennsylvania in Philadelphia.

[Read More]

Lurie Cancer Center, NMDTI, Northwestern Memorial launch new research program

Friday, February 6, 2015

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, in collaboration with the Northwestern Medicine Developmental Therapeutics Institute (NMDTI) and Northwestern Memorial Hospital, has launched a new research program, Northwestern Onco-SET (Sequence, Evaluate, Treat), to provide a more personalized, precision medicine option for cancer patients by combining oncology with genomics. This program initially will focus on patients with any type of cancer that is not responsive to traditional therapies.

[Read More]